const questions = [
  {
    id: 1,
    question:
      "Choose 3 statements that closely resembles your choice of using OMNIPAQUE scan after scan in your practice ",
    options: [
      {
        topic: "EXPERIENCE - PUBLICATION AFTER PUBLICATION",
        data: "Development of Iohexol set the gold standard for non-ionic imaging; Omnipaque is the first contrast medium to be subject to blinded studies on a large, systematic scale<sup>1,2</sup> ",
      },
      {
        topic: "EDUCATION & SUPPORT - SOLUTION AFTER SOLUTION",
        data: "GE HealthCareâ€™s expert team of advisors & application specialists host educational sessions for our departments<sup>15,16</sup> ",
      },
      {
        topic: "LEGACY - CASE AFTER CASE",
        data: "Distinguished by a breadth of clinical data, a Billion doses of Omnipaque is a testament to the trust clinicians have in us to deliver for over a 40 years<sup>17</sup>",
      },
      {
        topic: " QUALITY - IMAGE AFTER IMAGE",
        data: "From Extraction of Iodine, API production to Injection, GE Healthcare secures quality production & supply of Iodinated contrast medium<sup>18,19</sup> ",
      },
      {
        topic: " EFFICIENCY - SCAN AFTER SCAN",
        data: "Tailored efficiency solutions & saving cost with the convenience of 500 ml multi-dose vials. Pluspak packaging supports department productivity<sup>20-25</sup>  ",
      },
      {
        topic: " EFFICACY - DOSE AFTER DOSE",
        data: "Head-to-head clinical studies across a range of indications have shown that Omnipaque has not been surpassed by any other LOCM for its diagnostic efficacy <sup>3-14</sup> ",
      },
    ],
  },
];
export default questions;
